Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy.

Hai ChengYingjun SunXiaoxue ZhangZihan ChenLingyan ShaoJiaying LiuDandan WangYegan ChenXue WangWei ChenWei SangKunming QiZhenyu LiCai SunMing ShiJianlin QiaoQingyun WuLingyu ZengJunnian ZhengKailin XuJiang Cao

Published in: Cytotherapy (2024)

Overall, this study highlights the potential beneficial effect of a higher BMI on CAR-T cell therapy outcomes.

Keyphrases

cell therapy
multiple myeloma
stem cells
mesenchymal stem cells
acute lymphoblastic leukemia
acute myeloid leukemia
diffuse large b cell lymphoma
single cell
hodgkin lymphoma
type diabetes
metabolic syndrome
weight gain
human health
glycemic control
climate change
weight loss